nurexone

Pharmaceutical company based in Israel, founded in 2011, focusing on developing treatments for nervous system injuries by regenerating and rewiring neurons. Nurexone Biologic Inc. differentiates itself by leveraging advanced biological techniques to promote neural regeneration, aiming to provide innovative solutions for conditions that currently have limited treatment options. The company's primary target demographic includes patients suffering from nervous system injuries and medical professionals seeking advanced therapeutic options in neurology.